Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off─the─shelf RNA─based immunotherapies, announces it has been...
Vous n'êtes pas connecté
Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off─the─shelf RNA─based immunotherapies, announces it has been awarded a grant of just over £500,000 (approximately $658,000
Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off─the─shelf RNA─based immunotherapies, announces it has been...
LEIDEN, Netherlands, Sept. 13, 2024. Vico Therapeutics B.V., a clinical-stage genetic medicines company developing therapies for severe neurological...
Scientists have made a major breakthrough in neuroscience, developing a novel RNA-based nasal spray, COG-201, that has shown remarkable promise in...
By: Isak Möller AC Milan will kick off their Champions League campaign in just over a week, taking on Liverpool at San Siro, but the tickets...
Germany’s Cyber Agency has awarded Australian company Quantum Brilliance and Germany’s ParityQC one of three contracts valued at €35 million...
Monrovia – The governments of Liberia and Japan have signed a new KR Food Assistance Scheme valued at 400 million Japanese Yen (approximately US$3...
Monrovia – The governments of Liberia and Japan have signed a new KR Food Assistance Scheme valued at 400 million Japanese Yen (approximately US$3...
px Group, the Teesside based infrastructure solutions business, has been awarded an operations and maintenance contract by green energy solutions...
Current owner Brian Ainscough is understood to have interest from two groups – one based in Europe – to keep club afloat.
By Mohamed Chebaro Every time a newly elected UK leader sets off to see the American president of the day, the press in Britain and some in the US...